Industries > Pharma > Global Pre-Filled Syringes Market Forecast 2019-2029

Global Pre-Filled Syringes Market Forecast 2019-2029

Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors, Insulin Therapies, Rheumatoid Arthritis (RA) Therapies, Growth Hormones, Vaccines, PCSK9 Inhibitors

PUBLISHED: 31 January 2019
PAGES: 274
PRODUCT CODE: PHA0353
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global pre-filled syringes market was valued at $9.8bn in 2018. This market is estimated to grow at a CAGR of 12.9% in the first half of the forecast period. In 2018, the glass pre-filled syringes submarket held 53% of the global pre-filled syringes.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report, you will find 274-page report and you will receive 101 tables and 86 figures – all unavailable elsewhere.

The 274-page report provides clear detailed insight into the global pre-filled syringes market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pre-Filled Syringes market forecasts from 2019-2029

• Pre-Filled Syringes submarket forecasts by type from 2019-2029 covering:
• Glass Pre-Filled Syringes
• Pen Injectors and Autoinjectors
• Plastic Pre-Filled Syringes

• Forecasts from 2019-2029 of the leading therapeutic sectors for the Pre-Filled Syringes market:
• Insulin Therapies
• Rheumatoid Arthritis (RA) Therapies
• Growth Hormones
• Vaccines
• PCSK9 Inhibitors

• Pre-Filled Syringes national market forecasts from 2019-2029, covering:
• United States
• Japan
• Germany
• France
• United Kingdom
• Italy
• Spain
• Brazil
• Russia
• India
• China

Global Pre-Filled Syringes Market Forecast 2019-2029

Each national market is further segmented by type and application.

• Forecasts from 2019-2029 of selected leading products:
• Enbrel
• Genotropin
• Humalog
• Humira
• Humulin
• Lantus
• Levemir
• Norditropin
• NovoMix
• NovoRapid/Novolog
• Praluent
• Repatha
• Rituxan
• Toujeo
• Trulicity

• Assessment of the leading pre-filled syringes manufacturers and related technology manufacturers.

SWOT and STEP analysis of the global pre-filled syringes market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Pre-Filled Syringes Market and leading companies. You find data, trends and predictions.

Buy our report today Global Pre-Filled Syringes Market Forecast 2019-2029: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors. Insulin Therapies. Rheumatoid Arthritis (RA) Therapies, Growth Hormones, Vaccines, PCSK9 Inhibitors.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Pre-Filled Syringes Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Pre-Filled Syringes Market Forecast 2019-2029


Latest Pharma news

“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain

It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.

16 October 2019

READ

“Global nephrology and urology devices market is anticipated to surpass USD 39 Bn by 2030”, says Visiongain

Nephrology is a field of medicine that is concerned with studying kidney function, treating kidney issues, and therapy for renal substitute.

16 October 2019

READ

“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain

Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

16 October 2019

READ

“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain

The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.

16 October 2019

READ

Categories

Category